Skip to main content
Top
Published in: AIDS and Behavior 9/2013

01-11-2013 | Original Paper

Use of a Novel Technology to Track Adherence to Product Use in a Microbicide Trial of Short Duration (MTN-007)

Authors: Cheng-Shiun Leu, Marina Mabragaña, Rebecca Giguere, Curtis Dolezal, Alex Carballo-Diéguez, Ian McGowan

Published in: AIDS and Behavior | Issue 9/2013

Login to get access

Abstract

Adherence measurement in microbicide trials is challenging. To decrease recall and social desirability bias, we used an interactive voice response system (IVR) in a rectal microbicide trial. Forty-six participants were asked to report product use daily for 1 week. Participants received an incentive per call plus a bonus for calling every day. We examined adherence to calling the IVR and to gel use; we compared the latter to applicator counts. Adherence to calling the IVR daily was high (mean = 89.9 %, SD = 20.7 %). Adherence to gel use per IVR was very good (mean = 90.7 %, SD = 19.1 %), and consistent with applicator counts in 80.4 % of cases. Neither adherence to calling nor gel use were associated with temporal factors like day calls started, number of days since first call, or weekday vs. weekend. Daily reporting allowed identification of irregular product use. IVR appears useful for daily reporting in brief trials.
Literature
1.
go back to reference Muchomba FM, Gearing RE, Simoni JM, El-Bassel N. State of science of adherence in pre-exposure prophylaxis and microbicide trials. J Acquir Immune Defic Syndr. 2012;61(4):490–8.PubMedCrossRef Muchomba FM, Gearing RE, Simoni JM, El-Bassel N. State of science of adherence in pre-exposure prophylaxis and microbicide trials. J Acquir Immune Defic Syndr. 2012;61(4):490–8.PubMedCrossRef
2.
go back to reference Mensch B, Hewett P, Abbott S, Rankin J, Littlefield S, Ahmed K, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2011;15(2):407–21.PubMedCrossRef Mensch B, Hewett P, Abbott S, Rankin J, Littlefield S, Ahmed K, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2011;15(2):407–21.PubMedCrossRef
3.
go back to reference Van der Straten A, Montgomery E, Pillay D, Cheng H, Naidoo A, Cele Z. Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa. AIDS Behav. 2013;17(2):1–9.CrossRef Van der Straten A, Montgomery E, Pillay D, Cheng H, Naidoo A, Cele Z. Feasibility, performance, and acceptability of the Wisebag™ for potential monitoring of daily gel applicator use in Durban, South Africa. AIDS Behav. 2013;17(2):1–9.CrossRef
4.
go back to reference Haberer J, Robbins G, Ybarra M, Monk A, Ragland K, Weiser S, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16(2):375–82.PubMedCrossRef Haberer J, Robbins G, Ybarra M, Monk A, Ragland K, Weiser S, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16(2):375–82.PubMedCrossRef
5.
go back to reference Haberer J, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340–6.PubMedCrossRef Haberer J, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340–6.PubMedCrossRef
6.
go back to reference Austin MN, Rabe LK, Hillier SL. Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis. 2009;36(6):368–71.PubMedCrossRef Austin MN, Rabe LK, Hillier SL. Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis. 2009;36(6):368–71.PubMedCrossRef
7.
go back to reference Mauck CK, Schwartz JL. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. Sex Transm Dis. 2012;39(9):713–5.PubMedCrossRef Mauck CK, Schwartz JL. Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials. Sex Transm Dis. 2012;39(9):713–5.PubMedCrossRef
9.
go back to reference Mensch BS, Hewett PC, Erulkar A. The reporting of sensitive behavior by adolescents: a methodological experiment in Kenya. Demography. 2003;40(2):247–68.PubMedCrossRef Mensch BS, Hewett PC, Erulkar A. The reporting of sensitive behavior by adolescents: a methodological experiment in Kenya. Demography. 2003;40(2):247–68.PubMedCrossRef
10.
go back to reference Tolley EE, Harrison PF, Goetghebeur E, Morrow K, Pool R, Taylor D, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2010;14(5):1124–36.PubMedCrossRef Tolley EE, Harrison PF, Goetghebeur E, Morrow K, Pool R, Taylor D, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2010;14(5):1124–36.PubMedCrossRef
11.
go back to reference Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE. 2010;5(7):e11600.PubMedCrossRef Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE. 2010;5(7):e11600.PubMedCrossRef
12.
go back to reference Schroder KEE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.PubMedCrossRef Schroder KEE, Johnson CJ. Interactive voice response technology to measure HIV-related behavior. Curr HIV/AIDS Rep. 2009;6(4):210–6.PubMedCrossRef
13.
go back to reference Hensel DJ, Harezlak J, Craig D, Fortenberry JD. The feasibility of cell phone based electronic diaries for STI/HIV research. BMC Med Res Methodol. 2012;12(1):75.PubMedCrossRef Hensel DJ, Harezlak J, Craig D, Fortenberry JD. The feasibility of cell phone based electronic diaries for STI/HIV research. BMC Med Res Methodol. 2012;12(1):75.PubMedCrossRef
14.
go back to reference Bradley J, Ramesh BM, Rajaram S, Lobo A, Gurav K, Isac S, et al. The feasibility of using mobile phone technology for sexual behaviour research in a population vulnerable to HIV: a prospective survey with female sex workers in South India. AIDS Care. 2012;24(6):695–703.PubMedCrossRef Bradley J, Ramesh BM, Rajaram S, Lobo A, Gurav K, Isac S, et al. The feasibility of using mobile phone technology for sexual behaviour research in a population vulnerable to HIV: a prospective survey with female sex workers in South India. AIDS Care. 2012;24(6):695–703.PubMedCrossRef
15.
go back to reference Morrison DM, Leigh BC, Gillmore MR. Daily data collection: a comparison of three methods. J Sex Res. 1999;36(1):76–81.CrossRef Morrison DM, Leigh BC, Gillmore MR. Daily data collection: a comparison of three methods. J Sex Res. 1999;36(1):76–81.CrossRef
16.
go back to reference Minnis AM, Padian NS. Reliability of adolescents’ self-reported sexual behavior: a comparison of two diary methodologies. J Adolesc Health. 2001;28(5):394–403.PubMedCrossRef Minnis AM, Padian NS. Reliability of adolescents’ self-reported sexual behavior: a comparison of two diary methodologies. J Adolesc Health. 2001;28(5):394–403.PubMedCrossRef
17.
go back to reference Kranzler HR, Abu-Hasaballah K, Tennen H, Feinn R, Young K. Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study. Alcohol Clin Exp Res. 2004;28(7):1060–4.PubMedCrossRef Kranzler HR, Abu-Hasaballah K, Tennen H, Feinn R, Young K. Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study. Alcohol Clin Exp Res. 2004;28(7):1060–4.PubMedCrossRef
18.
go back to reference Tourangeau R, Smith TW. Asking sensitive questions: the impact of data collection mode, question format, and question context. Public Opin Q. 1996;60(2):275–304.CrossRef Tourangeau R, Smith TW. Asking sensitive questions: the impact of data collection mode, question format, and question context. Public Opin Q. 1996;60(2):275–304.CrossRef
19.
go back to reference Bender BG, Apter A, Bogen DK, Dickinson P, Fisher L, Wamboldt FS, et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med. 2010;23(2):159–65.PubMedCrossRef Bender BG, Apter A, Bogen DK, Dickinson P, Fisher L, Wamboldt FS, et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med. 2010;23(2):159–65.PubMedCrossRef
20.
go back to reference Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.PubMedCrossRef Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.PubMedCrossRef
21.
go back to reference McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, et al. A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1 % gel (MTN-007). PLoS ONE. 2013;8(4):e60147.PubMedCrossRef McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, et al. A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1 % gel (MTN-007). PLoS ONE. 2013;8(4):e60147.PubMedCrossRef
22.
go back to reference Stritzke W, Dandy J, Durkin K, Houghton S. Use of interactive voice response (IVR) technology in health research with children. Behav Res Methods. 2005;37(1):119–26.PubMedCrossRef Stritzke W, Dandy J, Durkin K, Houghton S. Use of interactive voice response (IVR) technology in health research with children. Behav Res Methods. 2005;37(1):119–26.PubMedCrossRef
Metadata
Title
Use of a Novel Technology to Track Adherence to Product Use in a Microbicide Trial of Short Duration (MTN-007)
Authors
Cheng-Shiun Leu
Marina Mabragaña
Rebecca Giguere
Curtis Dolezal
Alex Carballo-Diéguez
Ian McGowan
Publication date
01-11-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0549-2

Other articles of this Issue 9/2013

AIDS and Behavior 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.